IMMUNE-MEDIATED GASTROINTESTINAL DISORDER

IMMUNE-MEDIATED GASTROINTESTINAL DISORDER was reported 43 times

IMMUNE-MEDIATED GASTROINTESTINAL DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIVOLUMAB AND RELATLIMAB-RMBW 1 0.0019
1 ROPEGINTERFERON ALFA-2B 1 0.0005
2 IPILIMUMAB 17 0.0004
3 AVELUMAB 1 0.0002
4 PEMBROLIZUMAB 19 0.0002
5 NIVOLUMAB 17 0.0002
6 DURVALUMAB 2 0.0001
7 TRASTUZUMAB 5 0.0001
8 OXALIPLATIN 5 0.0001
9 CARBOPLATIN 8 0.0001
10 GEMCITABINE HYDROCHLORIDE 3 0.0001
11 ATEZOLIZUMAB 2 0.0001
12 PACLITAXEL 4 0.0000
13 OCTREOTIDE ACETATE 1 0.0000
14 METOCLOPRAMIDE HYDROCHLORIDE 2 0.0000
15 IRBESARTAN 1 0.0000
16 ADALIMUMAB-FKJP 1 0.0000
17 ADALIMUMAB-AATY 1 0.0000
18 ADALIMUMAB-ADAZ 1 0.0000
19 RUXOLITINIB 1 0.0000
20 DULAGLUTIDE 1 0.0000
21 ZOLPIDEM TARTRATE 1 0.0000
22 METHYLPREDNISOLONE 1 0.0000
23 SECUKINUMAB 1 0.0000
24 PREDNISONE 3 0.0000
25 TIRZEPATIDE 1 0.0000
26 INFLIXIMAB 1 0.0000
27 AMLODIPINE 1 0.0000
28 PREGABALIN 1 0.0000
29 ADALIMUMAB 2 0.0000
30 DUPILUMAB 1 0.0000